Promo – BioInformatics Gate

Course Content

Before You Start: Book Club Orientation

0/2

Book Club System: How It Works & How You Win

Advances in Computational Toxicology: Methodologies and Applications in Regulatory Science

0/1

Advances in Computational Toxicology: Methodologies and Applications in Regulatory Science

Chapter 1

0/7

1 1 Computational Toxicology

1 2 Domain of Computational Toxicology

1 3 Need for Computational Toxicology

1 4 Methods in Computational Toxicology

1 5 Potential Applications of Computational Toxicology in Regulatory Science

1 6 Conclusions

Chapter 2

0/10

ST Chapter 2 Background, Tasks, Modeling Methods, and Challenges for Computational Toxicology

2 2 Tasks for Computational Toxicology

2 2 2 Shaping Digitized Predictive Toxicology

2 3 Modeling Methods for Computational Toxicology

2 3 2 Physiologically Based Toxicokinetics Models

2 3 4 Molecular Models

2 3 5 QSAR Models

2 4 Challenges for Computational Toxicology

2 4 2 In the Face of Complex Living Systems

2 4 3 The Everlasting List of Interlinked Chemicals as Mixtures

Chapter 3

0/8

3 1 Introduction

3 2 Lessons Learnt from Successful Models

3 3 Making Negative Predictions

3 4 Moving to Quantitative Predictions and Weight of Evidence Approac

3 5 Enabling Expert Review

3 6 Modelling Complex Endpoints

3 7 Conclusion and Future Directions

Chapter 4

0/13

4 1 Introduction

4 2 Machine Learning Methods

4 2 2 Latent Dirichlet Allocation

4 2 3 Group Factor Analysis

4 2 4 Tensor Factorization

4 2 5 Multi tensor Factorization Multi

4 3 Selected Case Studies

4 3 2 Multi view Toxicogenomic Using Group Factor Analysis

4 3 3 Structural Toxicogenomic Using Multi tensor Factorization

4 3 4 Predictive Toxicogenomic Space PTGS

4 5 Conclusion and Future Directions

Chapter 5

0/8

5 1 Introduction

5 2 Method and Materials 5 2 1 Computers

5 2 3 Reconstruction of the Human Protein Protein Interactome

5 2 4 Collection of Disease Associated GenesProteins

5 2 5 Network Proximity

5 3 ResultsCase Studies

5 4 Conclusion and Future Directions

Chapter 6

0/13

Mode of Action Guided, Molecular Modeling Based Toxicity Prediction ANovel Approac

6 1 Introduction

6 1 1 Highlights of Recent Progress in the Development of Alternative Testing Methods

6 1 2 Mechanism Based Toxicity Prediction MIE and “Critical Target” Concept

6 1 3 Limitations of Current In Vitro and In Silico Approaches

6 1 4 Molecular Docking for Virtual Chemical Screening AGreen Toxicology Approach

6 2 Methodology 6 2 1 Approach Overview

6 2 2 Approach Implementation

6 3 2 Structural Models of Biomacromolecular Targets

6 3 4 In Vitro Toxicity Prediction Mode Libraries

6 5 Conclusion and Future Directions

Chapter 7

0/14

AReview of Feature Reduction Methods for QSAR Based Toxicity Prediction Abstract

7 1 Introduction

7 2 Feature Selection

7 2 2 2 Heuristic Selection Algorithms

7 2 4 Hybrid and Ensemble Feature Selection

7 3 1 Principal Component Analysis

7 3 2 Autoencoder

7 3 3 Linear Discriminant Analysis

73 7 4 Miscellaneous 7 4 1 Feature Stability It is

7 4 2 Validation of Feature Selection

Chapter 8

0/8

AnOverview of National Toxicology Program’s Toxicogenomic Applications DrugMatrix and ToxF

8 1 Introduction and History

8 2 DrugMatrix Data

8 3 DrugMatrix Database

8 4 DrugMatrix GUI

8 6 Example Analysis of dE 71 Gene Expression Data Using DrugMatrix and ToxFX

8 7 Accessing the DrugMatrix Database

Chapter 9

0/15

Chapter 9 APair Ranking PRank Method for Assessing Assay Transferability Among the Toxicogenom

9 1 Introduction

9 2 KeyQuestions in Toxicogenomics

9 2 2 In Vitro Testing Systems

9 3 Pair Ranking PRank Method

9 4 Toxicogenomics Data and Annotation Resources 9 4 1 Open TG GATE

9 4 2 Drug Induced Liver Injury DILI Annotation

9 4 3 Therapeutic Categories

9 4 5 Code Availability

9 5 Case Studies

9 5 2 Short Term Assays Show the Potential to Replace Long Term Assays

9 5 3 TGx Assay Transferability Is Endpoint Dependent

9 5 4 Concordance Among TGx Assays is Adverse Outcome Pathway AOP Specific

9 5 5 Toward Biological Data Based Read Across

9 6 Closing Remarks

Chapter 10

0/19

10 1 Introduction

10 2 History of MD Simulations

10 3 Types of MDSimulations

10 3 3 Classical MD

10 4 MDSimulation Software

10 5 MDSimulation Protocol

10 5 2 Preparation of the Protein Structure

10 5 3 Generating Topology and Parameter Files

10 5 4 Solvating the System

10 5 9 Analyzing Trajectory

10 6 Applications of MD Simulation

10 6 2 Identification of the Ligand Binding Mode in α Fetoprotein

10 6 3 Ligand Binding Interactions of Human α7 Nicotinic Acetylcholine Receptor

10 6 4 Antagonist Binding Induced AR Structural Changes

10 7 Future Perspectives

Chapter 11

0/8

11 2 Decision Domain

11 2 1 Applicability

11 2 2 Reliability

11 2 3 Decidability

11 5 Conclusion

Chapter 12

0/12

Application of Computational Methods for the Safety Assessment of Food Ingredie

12 1 Introduction

12 2 Computational Approaches Currently Used in Food Ingredient Safety Assessments

12 2 2 TK Modeling and Simulation

12 2 2 2 Physiological TK Models

12 2 3 Bioinformatic Approaches for Analysis of Potential Allergenicity of Proteins

12 2 3 2 Criteria for Bioinformatic Analysis

12 2 4 OFAS’s Food Ingredient Knowledgebase CERES In addition

12 3 Current Challenges and Future Directions

12 3 2 TK Modeling and Simulation

12 3 3 Bioinformatic Approaches for Allergenicity

12 4 Conclusions

Chapter 13

0/8

Predicting the Risks of Drug Induced Liver Injury in Humans Utilizing Computationa

13 1 Introduction

13 2 Annotation of DILI Risk for Marketed Drugs

13 3 Predictive Models Developed at NCTR

13 3 2 DILI Score Model 12

13 3 3 Conventional QSAR 13

13 3 4 Modified QSAR Models

13 4 Conclusion

Chapter 14

0/10

14 1 Introduction

14 2 Method and Materials

14 2 2 In Vivo Toxicity Modeling

14 3 ResultsCase Studies

14 3 2 Expanding Biological Space Coverage Improves HumanToxicity Prediction

14 3 2 Expanding Biological Space Coverage Improves HumanToxicity Prediction

14 3 3 The Tox21 Data Challenge—New Methods for Data Modeling Thehigh

14 4 Discussion Notes

14 5 Conclusions and Future Directions

Chapter 15

0/6

15 1 Introduction

15 2 Infer In Vivo PODs with Transcriptomic Data from the Same Tissues

15 2 2 Important Issues for Inferring PODs from Transcriptomic Data

15 3 PODsBased on In Vitro Assays

15 5 Conclusions

Chapter 16

0/10

Molecular Modeling Method Applications Abstract

16 1 Introduction

16 2 Preparation of 3D Biomacromolecule Structures

16 3 Preparation of the Molecular Structure of EDC Molecule

16 4 Obtaining the EDC—Biomacromolecule Complexes 16 4 1 Performing Molecular Docking

16 4 2 Refining the Complex

16 5 Probing the Underlying Binding Mechanism of Action

16 5 2 Analyzing Noncovalent Interactions

16 5 3 Calculating Binding Energy

16 6 Conclusions and Future Directions

Chapter 17

0/12

17 1 Introduction

17 1 2 Molecular Simulation of Typical Xenobiotics Metabolism Catalyzed by P450 Enzymes

17 1 2 2 Catalytic Cycle of P450 Enzymes and Related Common

17 2 Method and Materials

17 3 2 Case Studies Simulating Xenobiotic Chemical Metabolism by P450 Enzymes

17 3 2 2 Mechanisms for Dihydroxylation of PBDEs and Dioxin

17 3 2 3 Simulation of the Metabolism of Perfluorooctane Sulfonat

17 3 2 4 Metabolism of Halogenated Alkanes and Alkenes Catalyzed

17 3 2 5 Metabolism of Substituted Phenolic Compounds Catalyzed

17 4 Conclusion and Future Directions

Chapter 18

0/13

18 1 Introduction

18 2 Method and Materials 18 2 1 The VEGAHUBStructure

18 2 2 The QSAR Models in VEGA

18 2 3 The ToxRead Software

18 2 4 The ToxWeight Software

18 2 5 The ToxDelta Software

18 2 6 The JANUS Software

18 3 Results 18 3 1 The VEGA Software

18 3 2 Other Programs for Read Across

18 3 3 The JANUS Software

18 4 Discussion

18 5 Conclusion and Future Directions

Chapter 19

0/13

19 1 Introduction

19 2 Proposed Principle of Reproducibility for In Silico Modeling and Workflows and Implementa

19 3 Example 1 QSAR Model Building and Validation

19 4 Example 2 Integrated Testing Strategies

19 5 Best Practices in Data Management FAIR Principles,

19 6 Proposed Technology Solutions for Data Processing

19 7 Locating the Source of Irreproducibility Sub tasks and Intermediate Datasets

19 8 Use of Software Containers

19 9 Regulatory Acceptance Practices

19 10 Enhancing Workflow Solutions Including Trust

19 11 Preclinical Case Regulatory Acceptance of Workflows for Heterogeneous Knowledge Integra

19 12 Approach to Community Assessment of Best Practice Developments

Advances in Computational Toxicology: Methodologies and Applications in Regulatory Science | Book-Club |

0% Complete